Contract facts
UnrestrictedNo full NAICS 541990 intel page yet. Browse NAICS intelligence
NATIONAL COMPREHENSIVE CANCER NETWORK LICENSE is a federal Unrestricted award for Defense Health Agency held by National Comprehensive Cancer Network Inc. Estimated value $366K ($366K obligated). Current period of performance ends Apr 30, 2027. Last award drew 1 bidder. Place of performance: ARLINGTON VA.
NATIONAL COMPREHENSIVE CANCER NETWORK LICENSE
Recompete timing
PublicCurrent PoP ends Apr 30, 2027 (213 days remaining). Agencies typically plan 12–18 months ahead — at 7.0 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on HT003822P0004? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNational Comprehensive Cancer Network Inc — $217K obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT003822P0004?
HT003822P0004 (National comprehensive CANCER network license) is a Defense Health Agency award with a potential value of $366K, currently held by National Comprehensive Cancer Network Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT0038-22-P-0004?
HT0038-22-P-0004 is the dashed form of PIID HT003822P0004 (National comprehensive CANCER network license), held by National Comprehensive Cancer Network Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT003822P0004?
Defense Health Agency awarded HT003822P0004 to National Comprehensive Cancer Network Inc (potential $366K).
Who is the incumbent on HT003822P0004?
National Comprehensive Cancer Network Inc is the incumbent with $217K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Apr 30, 2027.
When does National Comprehensive Cancer Network Inc’s HT003822P0004 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT003822P0004? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.